Valganciclovir Tablet, Film Coated
Product Images NDC 0904-6796

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 0904-6796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

323351f4 9d68 40a8 B77e Aaf46cc0f1f2 00

323351f4 9d68 40a8 B77e Aaf46cc0f1f2 00
This is a description of a prescription drug called Valganciclovir Table USP. The packet contains unit doses of the drug and has an NDC code. The drug should be dispensed by a pharmacist without breaking or crushing the tablets. Each tablet contains 496.3 g of ValjanciconisHydochloide USP equivalent to 50 g of algancicloi. The usual dosage should be followed as per the product's instructions which can be found on inserts in the packaging or on the company website. The drug should be stored in a cool and dry place. The package should be kept away from children's reach. However, it is not possible to make sense of the text "&4" and "EEdImg", so the description is not complete.*
FDA Label Image

Camber

FDA Label Image

Formula

FDA Label Image

Formula2

Formula2
This appears to be a table showing the correlation between various parameters related to creatinine, such as height and serum levels, and creatinine clearance. The unit of measurement for creatinine clearance is mL/min/1.73m² and the unit for serum creatinine is mg/dL.*
FDA Label Image

Valganstructure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.